Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 14 studies | 25% ± 9% | |
peripheral blood | 11 studies | 24% ± 7% | |
brain | 7 studies | 28% ± 14% | |
intestine | 6 studies | 24% ± 11% | |
eye | 6 studies | 26% ± 5% | |
kidney | 5 studies | 26% ± 5% | |
liver | 5 studies | 19% ± 3% | |
uterus | 4 studies | 31% ± 14% | |
lymph node | 4 studies | 24% ± 11% | |
breast | 4 studies | 23% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 3576.84 | 653 / 653 | 100% | 121.32 | 602 / 605 |
prostate | 100% | 5046.46 | 245 / 245 | 99% | 231.14 | 498 / 502 |
liver | 100% | 1457.96 | 225 / 226 | 99% | 65.46 | 402 / 406 |
adrenal gland | 100% | 5044.10 | 258 / 258 | 98% | 161.27 | 226 / 230 |
kidney | 100% | 2960.42 | 89 / 89 | 98% | 90.56 | 885 / 901 |
brain | 100% | 3003.37 | 2638 / 2642 | 98% | 87.91 | 692 / 705 |
uterus | 100% | 3205.65 | 170 / 170 | 98% | 89.88 | 449 / 459 |
breast | 100% | 2821.83 | 459 / 459 | 97% | 134.25 | 1080 / 1118 |
intestine | 100% | 3066.27 | 966 / 966 | 96% | 68.39 | 505 / 527 |
pancreas | 100% | 1586.34 | 328 / 328 | 96% | 93.61 | 170 / 178 |
ovary | 100% | 3311.97 | 180 / 180 | 95% | 67.18 | 410 / 430 |
lung | 100% | 2364.66 | 576 / 578 | 96% | 66.24 | 1104 / 1155 |
bladder | 100% | 2904.43 | 21 / 21 | 95% | 85.85 | 479 / 504 |
stomach | 100% | 2195.17 | 359 / 359 | 94% | 57.17 | 269 / 286 |
skin | 100% | 1937.44 | 1807 / 1809 | 93% | 71.99 | 439 / 472 |
esophagus | 100% | 2417.03 | 1445 / 1445 | 91% | 35.78 | 167 / 183 |
lymph node | 0% | 0 | 0 / 0 | 100% | 95.64 | 29 / 29 |
spleen | 100% | 3447.72 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 344.98 | 1 / 1 |
blood vessel | 100% | 3035.68 | 1334 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 2332.32 | 1201 / 1204 | 0% | 0 | 0 / 0 |
heart | 99% | 1491.58 | 851 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 74.39 | 79 / 80 |
tonsil | 0% | 0 | 0 / 0 | 93% | 49.99 | 42 / 45 |
muscle | 87% | 708.52 | 699 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 84% | 1056.42 | 784 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006183 | Biological process | GTP biosynthetic process |
GO_0006915 | Biological process | apoptotic process |
GO_0009142 | Biological process | nucleoside triphosphate biosynthetic process |
GO_0006281 | Biological process | DNA repair |
GO_0008053 | Biological process | mitochondrial fusion |
GO_0006228 | Biological process | UTP biosynthetic process |
GO_0006241 | Biological process | CTP biosynthetic process |
GO_0005741 | Cellular component | mitochondrial outer membrane |
GO_0036064 | Cellular component | ciliary basal body |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0004550 | Molecular function | nucleoside diphosphate kinase activity |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0005524 | Molecular function | ATP binding |
Gene name | NME3 |
Protein name | Nucleoside diphosphate kinase (EC 2.7.4.6) nucleoside-diphosphate kinase (EC 2.7.4.6) Nucleoside diphosphate kinase 3 (NDK 3) (NDP kinase 3) (EC 2.7.4.6) (DR-nm23) (Nucleoside diphosphate kinase C) (NDPKC) (nm23-H3) |
Synonyms | |
Description | FUNCTION: Catalyzes the phosphorylation of ribonucleosides and deoxyribonucleoside diphosphates, other than ATP, into the corresponding triphosphates with ATP as the major phosphate donor . The ATP gamma phosphate is transferred to the nucleoside diphosphate beta phosphate via a ping-pong mechanism, using a phosphorylated active-site intermediate. Through the catalyzed exchange of gamma-phosphate between di- and triphosphonucleosides participates in regulation of intracellular nucleotide homeostasis . Inhibits granulocyte differentiation . May be required for ciliary function during renal development (By similarity). .; FUNCTION: Independently of its kinase activity, facilitates mitochondrial tethering prior to membrane fusion through its direct membrane-binding and hexamerization . Implicated in repair of both single- and double-stranded breaks in DNA through its association with the ribonucleotide reductase complex (RNR complex) via its interaction with the histone acetyltransferase KAT5, this interaction enables recruitment of NME3 at DNA damage sites where it plays a role in the repair of DNA, independently of its kinase activity . . |
Accessions | H3BMQ7 ENST00000568561.5 ENST00000564628.1 Q13232 H3BPD9 ENST00000563854.1 H3BRA8 H3BPR2 ENST00000219302.8 ENST00000563498.1 |